International Business: AstraZeneca shares fall on merger talks
Kort samengevat
AstraZeneca investors punished the drugmaker over reports of merger talks with US rival Bristol Myers Squibb about forming what would become one of the world’s biggest pharmaceutical firms with a combined value of nearly $400 billion.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Gdnonline.
Lees het volledige bericht ↗